Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tofacitinib by Biora Therapeutics for Ulcerative Colitis: Likelihood of Approval
Tofacitinib is under clinical development by Biora Therapeutics and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase...